The US FDA will fast-track potential antiviral medications to treat coronavirus, President Donald Trump announced at a White House briefing Thursday.
Category: US Pharmaceuticals
Tecentriq plus chemotherapy combination demonstrated a significant overall survival and progression-free survival benefit.Read More
The FDA has granted Ofev (nintedanib) a breakthrough therapy designation for chronic fibrosing interstitial lung disease, according to Boehringer Ingelheim.Read More
A panel of experts earlier this month recommended that the US Food and Drug...Read More
The US FDA has approved Nucala (mepolizumab) for use in children as young as six years old who are living with severe eosinophilic asthma.Read More
The US Food and Drug Administration approved Xenleta (lefamulin) to treat adults with...Read More